Everything below concerns GRF(1-29). We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-20. Numbers and descriptions here follow the published literature rather than marketing material.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | GHRH receptor agonist |
| Sequence length | 29 amino acids | Derived from human GHRH |
| Molecular weight | About 3368 Da without linker | Albumin-binding form is heavier |
| Appearance | White to off-white lyophilized powder | Common form for research reference material |
| Typical storage | -20 °C or below, desiccated | Protect powder from light and moisture |
Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Narratively, the game's setting was established early: an isolated British town in the 1960s where there were no children, and everyone else wore masks and took drugs. From that point, they worked backwards to create the history of the town, tying it to events from World War II, and recognizing that characters would have their own sins of the past as well as those of the entire town. In developing the title, Compulsion Games wanted the player to feel paranoia as they try to determine what actions they need to take in a moral gray area, and crafting "a simulation that provides an intelligent response and maintains [the player's] suspense of disbelief" based on how the player performs in the game. This in turn led to the use of light roguelike elements such as permadeath and procedurally generated worlds. Permadeath was added to try to implore a sense of danger to the player knowing that any action could lead to the end of the game, while the random generation would create tension as the player would need to relearn the layout of the town each time. Provost likened the concept to the survival game Don't Starve, though set in a 3D dystopian world. The procedural generation also fell out from Compulsion's previous experience in building Contrast, in that they recognized that as a five-person studio, they lacked the man-power to develop a lot of high-quality content. They opted to use random generation of the town both to address this, as well as a difficult challenge that had not been done before in video games.
The expected initial concentration of virus The product being purified The infective dose of the virus (for in vivo usage) Whether inactivation is a viable alternative to complete removal The capabilities of the laboratory The relative difficulty of the inactivation or removal method
his leeriness about being subject to oversight makes a lot more sense." St. James continued that when thinking about the MCU as a television series, many "common criticisms people tend to level at it take on a new context" such as complaints that the films are formulaic, lack "visual spark", or "shoehorn in story elements" that "are necessary to set up future films", all characteristics that "are fairly typical on television, where a director's influence is much lower than that of the showrunner", in this case, Feige. Comparing the films to the series Game of Thrones specifically, St. James noted that each solo film checks "in on various characters and their individual side stories, before bringing everyone together in the finale (or, rather, an Avengers film)", with Guardians of the Galaxy being equivalent to the character Daenerys Targaryen—"both separated by long distances from everybody else". She noted that this format was an extension of early "TV-like" film franchises such as Star Wars, as well as the format of the comics upon which the films are based. "I say all of this not to suggest that film franchises resembling TV series is necessarily a good trend", St. James concluded, "For as much as I generally enjoy the Marvel movies, I'm disheartened by the possibility that their particular form might take over the film industry ... But I also don't think it's the end of the world if Marvel continues on ... there's a reason TV has stolen so much of the cultural conversation over the past few decades.
Calmodulin-like protein 5 is a protein that in humans is encoded by the CALML5 gene. This gene encodes a novel calcium binding protein expressed in the epidermis and related to the calmodulin family of calcium binding proteins. Functional studies with recombinant protein demonstrate it does bind calcium and undergoes a conformational change when it does so. Abundant expression is detected only in reconstructed epidermis and is restricted to differentiating keratinocytes. In addition, it can associate with transglutaminase 3, shown to be a key enzyme in the terminal differentiation of keratinocytes. Human CALML5 genome location and CALML5 gene details page in the UCSC Genome Browser. Overview of all the structural information available in the PDB for UniProt: Q9NZT1 (Human Calmodulin-like protein 5) at the PDBe-KB.
Sources: en.wikipedia.org
Taurine given to a range of animal species is found to boost health and extend lifespan by up to 12%. 12 June – A time-use study provides the first comprehensive bird's-eye view of what humans currently spend their time on. The "global human day" framework enables better understanding, across fields of research, of the global human system in contexts such as technological change, civilization sustainability, global challenges or goals, societal changes, and economic time allocation. It identifies some factors of variations and activities "for which there is significant potential for change". 14 June Teams of researchers report creations of synthetic human model embryos from stem cells, without the need for sperm or egg cells (see also 1 August 2022), challenging legal, ethical, and biological concepts. Scientists report evidence that the planet Earth may have formed in just three million years, much faster than the 100 million years thought earlier. Astronomers report that the presence of phosphates on Enceladus, a moon of the planet Saturn, has been detected, completing the discovery of all the basic chemical ingredients for life on the moon. IBM computer scientists report that a quantum computer produced better results for a physics problem than a conventional supercomputer. A machine learning model is trained to recognise the key features of chemicals with senolytic activity. It finds three chemicals – ginkgetin, periplocin and oleandrin – able to remove senescent cells without damaging healthy cells.
The Ghana Prisons Service and the sub-division Borstal Institute for Juveniles administers incarceration. The new sustainable development goals adopted by the United Nations call for the international community to come together to promote the rule of law; support equal access to justice for all; reduce corruption; and develop effective, accountable, and transparent institutions at all levels. Ghana is used as a key narcotics industry transshipment point by traffickers, usually from South America and some from other African nations. In 2013, the UN chief of the Office on Drugs and Crime stated that "West Africa is completely weak in terms of border control and the big drug cartels from Colombia and Latin America have chosen Africa as a way to reach Europe." The social context within which narcotic trafficking, storage, transportation, and repacking systems exist in Ghana and the state's location along the Gulf of Guinea makes Ghana a more attractive country for the narcotics business. The Narcotics Control Board has impounded container ships at the Sekondi Naval Base in the Takoradi Harbour. These ships were carrying thousands of kilograms of cocaine, with a street value running into billions of Ghana cedis. Drug seizures saw a decline in 2011. Drug cartels are using new methods in narcotics production and narcotics exportation, to avoid Ghanaian security agencies. Underdeveloped institutions, porous open borders, and the existence of established smuggling organisations contribute to Ghana's position in the narcotics industry.
In 2018, the International Union for Conservation of Nature (IUCN) assessed the white shark as vulnerable worldwide, citing a population decline of 30–49% since approximately 1859. The species was further described as "moderately depleted" in 2021. The biggest threats to white sharks are accidental catching in fishing nets and the use of shark control measures—such as nets and traps—near beaches in Australia and South Africa. They nevertheless maintain a high survival rate when released from such gear. To regulate international trade, the species is listed under CITES Appendix II, requiring permits for the exchange of any specimens or parts. While a 2025 study estimated the global population at a minimum of roughly 5,800 individuals, co-author Gavin Naylor suggests the actual figure may be closer to 20,000.
Sources: en.wikipedia.org
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.
The label was first attached to the albumin-binding form during early development work. A shorter analog without the linker later became known by the same name in informal use. Published papers normally state which version was studied, so the methods section resolves the ambiguity.
It is a synthetic peptide rather than a steroid, and it does not occur naturally in the body. Its sequence is derived from a hypothalamic hormone called growth hormone-releasing hormone. It works as a receptor agonist rather than as a replacement for that hormone.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.